The Australian regulatory framework is shown below:

Regulatory Framework - TGAC / ODC

 Therapeutic Goods Order No. 93 (Standard for Medicinal Cannabis)

Narcotic Drugs Regulation 2016 

Further to the framework above, In 2018, changes were made to the export / import laws that, provided domestic supply of medicinal cannabis is not affected, enables export (under licence) of medicinal cannabis products manufactured in Australia under a GMP licence; medicinal cannabis products listed as export only, or registered on the Australian Register of Therapeutic Goods (ARTG); and extracts of cannabis manufactured under a Narcotic Drugs Act 1967. Imports and exports between countries including those made from low THC cannabis is tightly controlled and subject to international drug conventions.